One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papershttps://doi.org/10.1212/wnl.0000000000203868
Copy DOI Journal: Neurology |  Publication Date: Apr 25, 2023 |
 Citations: 2 |
Affiliation: Roche (Switzerland), Sahlgrenska University Hospital, University College London, National Hospital for Neurology and Neurosurgery, Wellcome Centre for Human Neuroimaging, Amsterdam University Medical Centers, Roche (United Kingdom), University of Toronto, Butler Hospital, Brown University, Roche (United States), Imperial College London, Rechts der Isar Hospital, Autism Research Institute, University of Southern CaliforniaGRADUATE I AND II: Findings of Two Phase III Randomized Placebo-controlled Studies Assessing the Efficacy and Safety of Subcutaneous Gantenerumab in Early Alzheimer’s Disease (AD) (S26.010)
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
